While immunomodulatory early-stage EPCs accumulate in the spleen and intensively infiltrate TME, tumor-promoting late-stage EPCs are detected mainly in the spleen where they secrete artemin into circulation [41,42,62,123]. The gene discussed is ARTN; the disease is neoplasm.